• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. LAP-BAND AP STANDARD WITH RAPIDPORT EZ; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. LAP-BAND AP STANDARD WITH RAPIDPORT EZ; ADJUSTABLE GASTRIC BAND Back to Search Results
Model Number B-2360
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Abdominal Pain (1685)
Date of Event 12/04/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Rapidport ez strain relief.Medwatch sent to fda on 02/06/2017.The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.Based on the serial number provided, the connecter type is assumed to be a rapidport ez strain relief.Device labeling addresses the reported event as follows: adverse events: it is important to discuss all possible complications and adverse events with your patient.Complications which may result from the use of this product include the risks associated with the medications and methods utilized in the surgical procedure, the risks associated with any surgical procedure and the patient's degree of intolerance to any foreign object implanted in the body.Other adverse events considered related to the lap-band system that occurred in fewer than 1% of subjects included: esophagitis, gastritis, hiatal hernia, pancreatitis, abdominal pain, hernia, incisional infection, infection, redundant skin, dehydration, gi perforation, diarrhea, abnormal stools, constipation, flatulence, dyspepsia, eructation, cardiospasm, hematemesis, asthenia, fever, chest pain, incision pain, contact dermatitis, abnormal healing, edema, paresthesia, dysmenorrhea, hypochromic anemia, band leak, cholecystitis, esophageal dysmotility, esophageal ulcer, esophagitis, port displacement, port site pain, spleen injury and wound infection.Warnings: patients should be advised that the lap-band ap system is a long-term implant.Explant (removal) and replacement surgery may be indicated at any time.Medical management of adverse reactions may include explantation.Revision surgery for explantation and replacement may also be indicated to achieve patient satisfaction.
 
Event or Problem Description
Reported as: a patient in the (b)(6) clinical study experienced "abdominal pain." patient was hospitalized and the lap-band was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND AP STANDARD WITH RAPIDPORT EZ
Common Device Name
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
MDR Report Key6306048
Report Number3006722112-2017-00029
Device Sequence Number565250
Product Code LTI
UDI-Device Identifier10811955020268
UDI-Public(01)10811955020268(11)150430(17)170430(10)2732143
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P000008
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2016
Reporter Type Manufacturer
Report Source health professional,study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date04/30/2017
Device Model NumberB-2360
Device Catalogue NumberB-2360
Device Lot Number2732143
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/09/2017
Initial Report FDA Received Date02/06/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PROTON PUMP INHIBITORS (PPIS)
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age46 YR
-
-